Pharmaceuticals

FDA grants approval for Addyi to treat HSDD in postmenopausal women

Freya Pharma Solutions rebrands as Arletta Pharma Solutions as company enters next stage of women’s healthcare development

Sofinnova Partners closes €650 million flagship fund as capital raised reaches €1.5bn in one year

Verastem Oncology sets price for $90 million Public Offering of shares and pre-funded warrants

Bahrain’s Mumtalakat signs AI partnership with SandboxAQ to advance drug discovery

Takeda signs $11 billion deal with China’s Innovent to expand cancer drug pipeline

Bayer’s Lynkuet® secures FDA approval as first dual neurokinin receptor therapy for menopausal hot flashes

Organon to discontinue OG-6219 development as endometriosis pain trial misses primary efficacy endpoint

AstraZeneca dethroned as UK’s most valuable company following U.S. drug price shake-up

Breaking Pills and Barriers: Women leading the charge in pharma innovation